Invivyd (IVVD) Change in Accured Expenses (2021 - 2025)

Invivyd (IVVD) reported Change in Accured Expenses of -$6.0 million for Q4 2025, up 62.49% on a YoY basis from -$3.7 million in Q4 2024, and up 75.77% quarter-over-quarter from -$24.8 million in Q3 2025.

Invivyd (IVVD) Change in Accured Expenses (2021 - 2025) Analysis & Trends

Invivyd has reported Change in Accured Expenses for 5 years, with the latest figure at -$6.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 62.49% year-over-year to -$6.0 million; the trailing twelve-month figure through Dec 2025 stood at -$30.8 million (down 385487.5% YoY), and the FY2025 full-year result was -$30.8 million, down 385487.5% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at -$6.0 million, up from -$24.8 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $20.3 million in Q1 2022, with the low at -$30.1 million in Q4 2021.
  • Historically, Change in Accured Expenses has averaged -$3.3 million across 5 years, with a median of -$3.0 million in 2023.
  • The largest YoY upside for Change in Accured Expenses was 248.77% in 2024 against a maximum downside of 53669.23% in 2024.
  • Invivyd's Change in Accured Expenses stood at -$30.1 million in 2021, then surged by 75.72% to -$7.3 million in 2022, then surged by 174.42% to $5.4 million in 2023, then plunged by 394.74% to -$16.0 million in 2024, then jumped by 62.49% to -$6.0 million in 2025.
  • The last three Change in Accured Expenses figures came in at -$6.0 million (Q4 2025), -$24.8 million (Q3 2025), and $10.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Invivyd 168.41 Mn -58.28 Mn - -6.02 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.02 Mn
Dec 31, 2025 -6.02 Mn
Sep 30, 2025 -24.83 Mn
Sep 30, 2025 -24.83 Mn
Jun 30, 2025 10.01 Mn
Jun 30, 2025 10.01 Mn
Mar 31, 2025 -10.01 Mn
Mar 31, 2025 -10.01 Mn
Dec 31, 2024 -16.04 Mn
Dec 31, 2024 -16.04 Mn
Sep 30, 2024 16.05 Mn
Sep 30, 2024 16.05 Mn
Jun 30, 2024 6.95 Mn
Jun 30, 2024 6.95 Mn
Mar 31, 2024 -6.96 Mn
Mar 31, 2024 -6.96 Mn
Dec 31, 2023 5.44 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 -10.79 Mn
Sep 30, 2023 -10.79 Mn